Peripheral Arterial Disease Market Segments 2024-2033 | Size, Share And Insights

The peripheral arterial disease market size has grown strongly in recent years. It will grow from $4 billion in 2023 to $4.36 billion in 2024 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to innovative medical devices, gene therapy and regenerative medicine, pharmacogenomics, digital health and remote monitoring.

The peripheral arterial disease market size is expected to see strong growth in the next few years. It will grow to $6.05 billion in 2028 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to interdisciplinary care teams, minimally invasive interventions, lifestyle and exercise prescriptions. Major trends in the forecast period include vascular tele-rehabilitation, multimodal pain management, wound care advances, public health campaigns.

Market Overview -
Peripheral arterial disease (PAD) refers to a medical condition characterized by the narrowing or blockage of the arteries that supply blood to the extremities, typically the legs and feet. It is a type of atherosclerosis, which is an accumulation of fat cells (plaque) in the arteries, leading to reduced blood flow. The treatment of the disease involves a combination of lifestyle modifications, medications and medical procedures aimed at increasing blood supply to the affected extremities, providing symptom relief and lowering the risk of consequences.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=12999&type=smp

Cardiac Disease Prevalence Fuels Growth In The Peripheral Arterial Disease Market
The rising prevalence of cardiac diseases is driving the growth of the peripheral arterial disease market going forward. Cardiac disease is a typical heart disease that impacts the main blood vessels supplying the heart muscle. Peripheral arterial disease treatment helps cardiac patients with improved blood flow, cardiovascular risk reduction, symptom relief and enhanced quality of life. For instance, in June 2023, according to the Center for Disease Control and Prevention, a US-based government agency, the number of deaths due to cardiovascular diseases reached 695,547 in 2021. Additionally, in April 2022, according to the American College of Cardiology, a US-based non-profit medical association, the risk factors for ischemic heart disease are predicted to increase by 30.7% to 29 million by 2025. Therefore, the rising prevalence of cardiac diseases drives the peripheral arterial disease market.

Competitive Landscape -
Major players in the peripheral arterial disease market are Cardinal Health Inc., Johnson and Johnson Limited, Abbott Laboratories, Medtronic PLC, Becton Dickinson and Company, Koninklijke Philips N.V., Boston Scientific Corporation, B. Braun SE, Terumo Corp., Cook Medical LLC, Penumbra Inc., Shockwave Medical Inc., AngioDynamics Inc., Cardiovascular Systems Inc., ACIST Medical Systems Inc., SurModics Inc., Endologix Inc., BioVentrix Inc., QT Vascular Ltd., Avinger Inc., Mercator MedSystems Inc., VentureMed Group Ltd., Eximo Medical Ltd., LimFlow SA, Contego Medical LLC.

Innovative Drug Development Initiatives Driving Advancements In The Peripheral Arterial Disease Market
Major companies operating in the peripheral arterial disease market are focused on developing innovative drugs and solutions to sustain their position in the market. Drug development can lead to the development of more effective treatments for PAD, reducing the risk of complications and improving patient outcomes. For instance, in August 2021, The Janssen Pharmaceutical Companies, a Belgium-based pharmaceutical company, received approval for an expanded peripheral artery disease (PAD) indication for the XARELTO (rivaroxaban) dose by the Food and Drug Administration (FDA), a US-based government agency. XARELTO is the first and only therapy for both coronary artery disease (CAD) and PAD, including PAD patients post-LER. This is also recommended for patients with acute limb ischemia and amputation, ischemic stroke and myocardial infarction.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/peripheral-arterial-disease-global-market-report

Key Segments -
The peripheral arterial disease market covered in this report is segmented -
1) By Treatment Type: Devices; Catheters; Drugs; Other Types
2) By Route of Administration: Oral; Parenteral; Other Route of Administrations
3) By End User: Hospitals; Specialty Clinics; Others End-Users

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

"Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model "

"Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps"

This release was published on openPR.